✦ LIBER ✦

CD4+ T-cell activation for immunotherapy of malignancies using Ii-Key/MHC class II epitope hybrid vaccines

✍ Scribed by Minzhen Xu; Nikoletta L. Kallinteris; Eric von Hofe

Book ID: 116964790
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 260 KB
Volume: 30
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2012.02.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activation of human CD4+ T cells by targ

Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences

✍ Kayvan R. Niazi; Maria-Teresa Ochoa; Peter A. Sieling; Nanette E. Rooke; Anna K. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

CD4+ T cell epitope affinity to MHC II i

CD4+ T cell epitope affinity to MHC II influences the magnitude of CTL responses elicited by DNA epitope vaccines

✍ Dimitrios N. Vatakis; Yi Ting Koh; Minnie McMillan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 215 KB

MHC class II restricted tumor antigens a

MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

✍ Suzanne L. Topalian 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 693 KB

Identification of two Melan-A CD4+ T cel

Identification of two Melan-A CD4+ T cell epitopes presented by frequently expressed MHC class II alleles

✍ Emmanuelle Godefroy; Luigi Scotto; Naira E. Souleimanian; Gerd Ritter; Lloyd J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 283 KB

CIITA-driven MHC-II positive tumor cells

CIITA-driven MHC-II positive tumor cells: Preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy

✍ Valeria Frangione; Lorenzo Mortara; Patrizia Castellani; Andrea De Lerma Barbaro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 987 KB

## Abstract In our study, we have investigated whether tumors of distinct histological origin can be rejected if expressing CIITA‐driven MHC class II molecules. Moreover, we assessed whether antitumor lymphocytes generated by this approach could be used as an immunotherapeutic tool for established

Use of class II tetramers for identifica

Use of class II tetramers for identification of CD4+ T cells

✍ William W Kwok; Nancy A Ptacek; Andrew W Liu; Jane H Buckner 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 455 KB